Brief: Immunoprecise Antibodies Receives Notice From European Patent Office
March 27 (Reuters) - Immunoprecise Antibodies Ltd
IPA.O :
* IMMUNOPRECISE ANTIBODIES LTD - RECEIVED OFFICIAL NOTICE
FROM
EUROPEAN PATENT OFFICE FOR DECISION TO GRANT ITS PATENT
APPLICATION ON APRIL 5TH, 2023
* IMMUNOPRECISE ANTIBODIES LTD - PATENT APPLICATION COVERS A
METHOD TO EFFICIENTLY HANDLE MASS BIOLOGICAL SEQUENCE
INFORMATION
Source text for Eikon: ID:nBw5xb5MMa
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai